Home
Raymed Labs Ltd PE Ratio

Raymed Labs Ltd
NSE: RAYMEDLABS
PE
Key Highlights
- The P/E Ratio of Raymed Labs Ltd is 0 as of 22 Feb 9.00 AM .
- The P/E Ratio of Raymed Labs Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
- The Latest Trading Price of Raymed Labs Ltd is ₹ 2.88 as of 27 Jan 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Raymed Labs Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Raymed Labs Ltd
Company Fundamentals for Raymed Labs Ltd

Raymed Labs Ltd
NSE: RAYMEDLABS
Share Price
Market Price of Raymed Labs Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
27 Jan 2025 | 2.88 |
13 Jan 2025 | 2.88 |
23 Dec 2024 | 2.88 |
11 Nov 2024 | 2.75 |
21 Oct 2024 | 2.75 |
23 Sep 2024 | 2.62 |
16 Sep 2024 | 2.62 |
09 Sep 2024 | 2.62 |
29 Jul 2024 | 2.5 |
08 Jul 2024 | 2.5 |
BlinkX Score for Raymed Labs Ltd
Asset Value vs Market Value of Raymed Labs Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Raymed Labs Ltd | 1.23 | - |
Sun Pharmaceuticals Industries Ltd | 394223 | 33.4 |
Divis Laboratories Ltd | 152610 | 73.8 |
Cipla Ltd | 119067 | 23.9 |
Torrent Pharmaceuticals Ltd | 102739 | 55.2 |
Dr Reddys Laboratories Ltd | 96124 | 17.9 |
Company | |
---|---|
Raymed Labs Ltd | 1.23 |
Sun Pharmaceuticals Industries Ltd | 394223 |
Divis Laboratories Ltd | 152610 |
Cipla Ltd | 119067 |
Torrent Pharmaceuticals Ltd | 102739 |
Dr Reddys Laboratories Ltd | 96124 |
PE Ratio of Raymed Labs Ltd Explained
₹1.23
Market cap
₹0
Earnings
0.0X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Raymed Labs Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Raymed Labs Ltd
Historical Revenue, EBITDA and Net Profit of Raymed Labs Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Raymed Labs Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Raymed Labs Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Raymed Labs Ltd
About Raymed Labs Ltd
- Raymed Labs Ltd was established in the year 1994 as a pharmaceutical company with emphasis on injectables with state of the art manufacturing facilities on Dehradun Road, Saharanpur, UP. The Company embarked on a new and exciting phase of its growth journey.
- As a widely operational pharmaceutical company, it proved excellence in the competitive ophthalmology industry with its robust marketing infrastructure across the geographies. Raymed created an integrated multi-technology capability to manufacture all types of formulations with innovative and advanced technologies focusing into Preservative free Ophthalmic dosage specially for Conjunctivitis and Glaucoma Patient care, Various other formulations have been converted from suspension to solution which helps in the effective absorption, penetration and better patience compliance.
Raymed Labs Ltd News Hub
Raymed Labs to convene AGM
Raymed Labs announced that the Annual General Meeting (AGM) of the company will be held on 18 Septem
Read more
17 Aug 24
Raymed Labs to convene AGM
Raymed Labs announced that the Annual General Meeting (AGM) of the company will be held on 18 Septem
Read more
16 Aug 24
Raymed Labs schedules AGM
Raymed Labs announced that the Annual General Meeting (AGM) of the company will be held on 18 Septem
Read more
16 Aug 24
Raymed Labs reports standalone net loss of Rs 0.02 crore in the June 2024 quarter
Net Loss of Raymed Labs reported to Rs 0.02 crore in the quarter ended June 2024 as against net loss
Read more
13 Aug 24